# Pusan National University Hospital

Organization · id `cardio:org-pusan-national-university-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 027zf7h57](<https://ror.org/027zf7h57>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 027zf7h57 by an exact name.

## The registry's words

- Sponsor name: Pusan National University Hospital
- Sponsor class: OTHER
- ROR name: Pusan National University Hospital

## Connected pages

- Sponsors: The Clinical Study to Evaluate the Efficacy and Safety of Fimasartan in Patients With Mild to Moderate Essential Hypertension (`cardio:ct-nct01135212`)
- Sponsors: Fimasartan/Amlodipine Combination Phase III (`cardio:ct-nct02152306`)
- Sponsors: Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin (`cardio:ct-nct02426294`)
- Sponsors: Hospital-based Diabetes Prevention Study in Korea (`cardio:ct-nct02981121`)
- Sponsors: Antioxidant and NMDA Receptor Blocker Wins Anoxic Brain Damage of KorEa OHCA Patients (`cardio:ct-nct03651557`)
- Sponsors: Glucose-Lowering Effects and Safety of Adding 0.25 or 0.5 mg Duvie (`cardio:ct-nct03770052`)

## Provenance

Content hash: f2fc13aefa029c0f9e7b290070e60dffe8654c8272ab393eae55e8241ac22f73
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
